Cancer Immunotherapy: A Treatment for the Masses
Joseph N. Blattman(Fred Hutch Cancer Center), Philip D. Greenberg(Fred Hutch Cancer Center)
Cited by 613
Abstract
Cancer immunotherapy attempts to harness the exquisite power and specificity of the immune system for the treatment of malignancy. Although cancer cells are less immunogenic than pathogens, the immune system is clearly capable of recognizing and eliminating tumor cells. However, tumors frequently interfere with the development and function of immune responses. Thus, the challenge for immunotherapy is to use advances in cellular and molecular immunology to develop strategies that effectively and safely augment antitumor responses.
Related Papers
Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma
Steven A. Rosenberg, James Chih‐Hsin Yang, Douglas J. Schwartzentruber et al.|Nature Medicine|1998|1.8k
Adoptive T cell therapy using antigen-specific CD8<sup>+</sup>T cell clones for the treatment of patients with metastatic melanoma:<i>In vivo</i>persistence, migration, and antitumor effect of transferred T cells
Cassian Yee, John A. Thompson, D. Byrd et al.|Proceedings of the National Academy of Sciences|2002|1.2k
Escape of Human Solid Tumors from T–Cell Recognition: Molecular Mechanisms and Functional Significance
Francesco M. Marincola, Elizabeth M. Jaffee, Daniel J. Hicklin et al.|Advances in immunology|1999|1.2k